Replies to post #13950 on NanoLogix Inc (NNLX)

[medical veteran]

jshdn- You statement is 100% correct.

"I imagine that given the very very long list of past partners, medtech companies, epa, overseas, domestic, many partners, people are just hoping to hear something from outside nanologix to make them think that this time is somehow different, that's all".

It would be nice to finally see something that has reoccurring revenue value that can return shareholder equity back to the long timers. Is that asking too much??

[Omar8]

jshdn........





We need to hear that a recognized company opening saying to the whole world they are partners with us and they will produce our tech to meet that demand out there . Our company bragging will only go so far. And mentioning "partners" in the vague sense means only so much, one has to guess what is really going on.





"June 3, 2020

NanoLogix Seeks Development & Marketing Partner for Their Sub 1-Hour COVID-19 Detection Tests

HUBBARD, Ohio, June 3, 2020 /PRNewswire/ -- NanoLogix, Inc. (OTC: NNLX), an innovator in the rapid detection and identification of viruses and bacteria, is seeking a partner or partners for obtaining FDA Emergency Use Authorization, if required, and for development and marketing of their sub 1-hour COVID-19 Point of Care modified-ELISA detection test. This Rapid Viral Assay can also be configured for other viruses, such as, but not limited to, HIV, HPV, Hepatitis, MERS, and SARS-1. A Home-Test version of the COVID-19 test has the potential of 30-minute results using a nasopharyngeal swab or saliva samples.

CEO Bret Barnhizer stated: "NanoLogix does not possess the scale of production or marketing required for this essential test distribution for COVID-19. We cannot expand rapidly enough to meet the immediate need for testing. We have entered into Confidentiality Agreements with two diagnostic and financial groups in the last week for this purpose and are inviting additional interest."

Jonathan Faro, MD, PhD., Chief Medical Officer stated: "We are extremely excited over this technology development. It is a novel approach in diagnostics that provides a solution to the inherent problems with false positives and false negatives present in those tests currently being used in the war against COVID-19."

[Omar8]

jshdn........



If this is one of the partners...it seems partial funding is by those below(, was the rest by the company) ? And the word of ENLISTED the service is used. I was hoping a partner would be one who was paying for this or a large percentage of it. Does enlisting someone elses' services make them a partner ? No real definition of partner is defined by the company is there ?




"Oct. 5, 2020

NanoLogix Covid-19 Detection Test Update

Partial Funding received from NanoLogix Directors Options Exercise

NanoLogix has enlisted the services of a company with an advanced diagnostic platform that can deliver lab-quality results at point-of-care (POC). That company will perform an initial feasibility assessment of our COVID-19 viral assay on their rapid POC system. Partial funding for the first phase of the feasibility assessment is being provided through NanoLogix Director and Chief Medical Officer Dr. Jonathan Faro and Director Dr. Sebastian Faro exercise of options for 3 million shares. Those exercised shares are restricted from trading for a period of one year from issuance

The Directors' action reflects their belief in the NanoLogix rapid viral detection technology and its potential.

Independent laboratory work in Houston on a separate phase and aspect of the testing technology will begin after initial results from the above-mentioned work.

[Omar8]

Jshdn........





Look how this is written below, this sounds like a what a real serious partner would be doing....not partial funding like those shares talked about. Not enlisting someone else to do something....A recognized company stepping up saying they will do pretty much do all the hard work and when they have serious skin in the game, you know what that means ? They will be working extremely hard to get it done and they would have the muscles to do it....so far we haven't heard of a partner doing those things. As far as we know it appears we have pieced together some others and trying to do the best they can.




"Mar. 15, 2020

NanoLogix Update - COVID-19 Detection

Last week the Company was contacted by a respected U.S. Government Contractor regarding our N-Assay Technology and its potential Coronavirus (COVID-19) testing capabilities.

We were informed by the contractor that they will bear all costs of configuration and testing of the N-Assay at their facilities. Following the conversation, NanoLogix sent a letter agreeing in principle to the proposal, which was rapidly acknowledged, and is awaiting a formal agreement from the contractor.

NanoLogix will not be supplying any materials or personnel for this process and our sole participation is on an Intellectual Property (Patent) basis, stemming from the N-Assay patent issued in 2015.

We will not be involved in the potential production of test kits if the contractor determines from the testing that N-Assay kits should be used in the fight against this Coronavirus. Should that happen, it would be done by a recognized producer under license.

We are hopeful that the N-Assay and one additional Point-of Care test we are developing will be useful tools for rapid detection of any pathogens that are threats to health.